Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts?

Ovid Therapeutics Inc. (NASDAQ:OVID) is one of the best fast growing penny stocks to buy according to analysts. Earlier on December 22, LifeSci Capital initiated coverage of Ovid Therapeutics with an Outperform rating and set a price target of $4.

Additionally, on December 18, Ovid Therapeutics Inc. (NASDAQ:OVID) announced successful Phase 1 results for OV350, the first-ever direct activator of the KCC2 transporter to be dosed in humans. The intravenous study met its primary objectives, showing a favorable safety and tolerability profile with no treatment-related serious adverse events or laboratory findings. Exploratory qEEG data further confirmed central activity and spectral power consistent with the expected physiological effects of KCC2 modulation in the brain.

Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts?

Photo by Robb Miller on Unsplash

While the company does not plan to advance the intravenous OV350 further, these results validate the mechanism and support the development of its oral KCC2 portfolio. Ovid is now prioritizing OV4071, an oral activator that is 20x more potent than OV350 in disease models. The company remains on track to submit a regulatory application for OV4071 in Q1 2026, with Phase 1/1b clinical trials expected to initiate in Q2 2026 for the treatment of psychoses associated with neurodegenerative conditions.

Ovid Therapeutics Inc. (NASDAQ:OVID) is a biopharmaceutical company that develops impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the US.

While we acknowledge the potential of OVID to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than OVID and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.